A bipartisan Senate bill offers a 25% tax credit for American-made PCBs and $3 billion in grants. Here's what hardware engineers and procurement teams need to know about the shifting economics of PCB sourcing.
The Bill: S.4569, Protecting Circuit Boards and Substrates Act
Senators Ruben Gallego (D-AZ) and Jim Justice (R-WV) introduced S.4569 on May 25, 2026, targeting the dramatic decline of U.S. PCB manufacturing. The bill is a companion to House version H.R. 3597.
Key provisions:
- 25% tax credit for purchasing American-manufactured PCBs
- $3 billion grant program for PCB manufacturer capacity expansion, equipment upgrades, and workforce development
- Focus on advanced boards: HDI, substrates, and technology-intensive PCBs critical for defense and advanced electronics
The Problem: 30% → 4% Market Share in 30 Years
The U.S. share of global PCB production has collapsed from 30% to just 4% over three decades. This wasn't just economic migration — it's now a national security concern:
- The DoD relies on PCBs in every weapons system, satellite, and communication platform
- Fewer than 150 domestic manufacturers remain
- COVID-19 exposed supply chain fragility (lead times went from weeks to months)
- As manufacturing left, process engineering expertise for advanced boards went with it
Following the CHIPS Act Playbook
The bill follows the successful CHIPS and Science Act (2022) model, which attracted $200+ billion in semiconductor fab investments. The logic: if chips need boards to function, reshoring chip production without reshoring PCB production creates a new bottleneck.
PCBAA Executive Director David Schild: "Every semiconductor needs a PCB to function. The challenge is that PCB production and know-how have been offshored to heavily subsidized industries in Asia."
What Changes for Engineers and Procurement
The 25% tax credit fundamentally changes cost calculations:
- A $10,000 order from a US fab effectively costs $7,500 after the credit
- Defense primes (already required to use domestic sources) improve margins
- Medical device companies gain financial incentive to near-shore
- High-reliability applications where quality concerns favor domestic production become more competitive
Current U.S. PCB manufacturing strengths:
- Quick-turn prototyping (2–10 day delivery)
- Military-spec boards (ITAR-controlled)
- Medical devices (FDA-regulated supply chains)
- Aerospace (AS9100 certified)
Current gaps:
- High-volume production remains overwhelmingly offshore
- Advanced HDI/substrate capability is limited domestically
- The grants could fund capital equipment (laser drills, plating lines, AOI) needed to close these gaps
Industry Implications
This legislation doesn't mandate domestic sourcing — it incentivizes it. The economics shift most significantly for:
- Mid-volume runs ($5K–$50K orders) where the tax credit percentage matters most
- Long-lead specialty boards where supply chain risk already favors domestic
- Defense/aerospace where ITAR compliance is already required
- Medical devices facing supply chain audit requirements
For high-volume consumer electronics, Asian production will likely remain dominant due to scale advantages. But for the professional, industrial, and defense segments? The math is changing.
Source: PCBAA / PCB Directory, May 25, 2026. Bill references: S.4569 (Senate), H.R. 3597 (House).
Top comments (0)